Association between descending pain modulatory system and cognitive impairment in fibromyalgia: A cross-sectional exploratory study.
cognitive impairment
descendant pain modulation system
fibrofog
fibromyalgia
working memory
Journal
Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
04
2022
accepted:
29
07
2022
entrez:
17
10
2022
pubmed:
18
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
The successful regulation of sensory input to the central nervous system depends on the descending pain modulatory system (DPMS). For the effective regulation of sensory input to the central nervous system and behavioral responses to pain, the DPMS is required. Its connection to fibromyalgia (FM)-related cognitive dysfunction has not yet been investigated. Therefore, this study tested whether measures of verbal fluency, sustained attention, and short-term and working memory could distinguish FM patients from healthy controls (HC). Additionally, it investigated, using a standardized paradigm, the link between cognitive ability and the function of the DPMS in responders and non-responders to the conditioned pain modulation test (CPM-test). We enrolled 21 HC women and 69 FM patients, all of whom ranged in age from 30 to 65. We employed scores from the Trail Making Test (TMTB-A) (sustained and divided attention), the Controlled Oral Word Association Test (COWAT) (orthographic and semantic fluency), and the Digits subtest of the Wechsler Adult Intelligence Scale (WAIS-III) as dependent variables. A generalized linear model (GLM) adjusted by educational level revealed significantly lower scores in FM than HC on the Span digits forward, COWAT-orthographic, and TMTB-A. For FM patients, multilevel MANCOVA revealed that the cognitive performance of non-responders compared to responders to CPM-test showed lower adjusted scores in Span digits forward (Partial-η Based on these findings, it can be shown that HC performed substantially better on cognitive exams than FM did. They demonstrated a link between clinical complaints about attention and memory and decreased DPMS effectiveness. Additionally, they demonstrated that the BDNF is a moderating element in a potential relationship between the severity of cognitive impairment and DPMS dysfunction.
Sections du résumé
Background
UNASSIGNED
The successful regulation of sensory input to the central nervous system depends on the descending pain modulatory system (DPMS). For the effective regulation of sensory input to the central nervous system and behavioral responses to pain, the DPMS is required. Its connection to fibromyalgia (FM)-related cognitive dysfunction has not yet been investigated. Therefore, this study tested whether measures of verbal fluency, sustained attention, and short-term and working memory could distinguish FM patients from healthy controls (HC). Additionally, it investigated, using a standardized paradigm, the link between cognitive ability and the function of the DPMS in responders and non-responders to the conditioned pain modulation test (CPM-test).
Materials and methods
UNASSIGNED
We enrolled 21 HC women and 69 FM patients, all of whom ranged in age from 30 to 65. We employed scores from the Trail Making Test (TMTB-A) (sustained and divided attention), the Controlled Oral Word Association Test (COWAT) (orthographic and semantic fluency), and the Digits subtest of the Wechsler Adult Intelligence Scale (WAIS-III) as dependent variables.
Results
UNASSIGNED
A generalized linear model (GLM) adjusted by educational level revealed significantly lower scores in FM than HC on the Span digits forward, COWAT-orthographic, and TMTB-A. For FM patients, multilevel MANCOVA revealed that the cognitive performance of non-responders compared to responders to CPM-test showed lower adjusted scores in Span digits forward (Partial-η
Conclusion
UNASSIGNED
Based on these findings, it can be shown that HC performed substantially better on cognitive exams than FM did. They demonstrated a link between clinical complaints about attention and memory and decreased DPMS effectiveness. Additionally, they demonstrated that the BDNF is a moderating element in a potential relationship between the severity of cognitive impairment and DPMS dysfunction.
Identifiants
pubmed: 36248031
doi: 10.3389/fnbeh.2022.917554
pmc: PMC9559397
doi:
Types de publication
Journal Article
Langues
eng
Pagination
917554Informations de copyright
Copyright © 2022 Serrano, Zortea, Alves, Beltran, Deliberali, Maule, Torres, Fregni and Caumo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nervenarzt. 2006 May;77(5):523-37
pubmed: 16078056
J Clin Exp Neuropsychol. 1995 Aug;17(4):529-35
pubmed: 7593473
Pain Med. 2012 Nov;13(11):1425-35
pubmed: 23036076
Pain Res Manag. 2016;2016:5719380
pubmed: 28127233
Pain Manag Nurs. 2004 Jun;5(2):75-93
pubmed: 15297954
Psychol Health. 2011 Jun;26(6):765-80
pubmed: 21391131
J Neurosci. 2006 Jan 4;26(1):126-37
pubmed: 16399679
J Clin Exp Neuropsychol. 1999 Aug;21(4):477-87
pubmed: 10550807
Br J Psychiatry. 2001 Mar;178:200-6
pubmed: 11230029
J Pain Res. 2016 Jun 28;9:457-67
pubmed: 27418853
Braz J Psychiatry. 2013 Oct-Dec;35(4):416-31
pubmed: 24402217
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):183-192
pubmed: 28797640
J Rheumatol. 2011 Oct;38(10):2238-46
pubmed: 21765102
Am J Geriatr Psychiatry. 2010 Aug;18(8):684-91
pubmed: 21399729
Elife. 2021 Feb 08;10:
pubmed: 33555256
Gend Med. 2005 Sep;2(3):137-45
pubmed: 16290886
Psychosom Med. 2018 Jun;80(5):432-438
pubmed: 29528888
Pain. 2015 Jun;156(6):1003-1007
pubmed: 25844555
Sci Rep. 2018 Aug 20;8(1):12477
pubmed: 30127510
Rheumatol Int. 2012 May;32(5):1135-42
pubmed: 21246363
Hum Brain Mapp. 2016 Apr;37(4):1349-60
pubmed: 26749315
Dement Neuropsychol. 2014 Jan-Mar;8(1):26-31
pubmed: 29213876
Rheumatol Int. 2015 Jul;35(7):1115-25
pubmed: 25583051
Pain. 2021 Nov 1;162(11):2629-2634
pubmed: 33974577
J Psychosom Res. 2016 Aug;87:30-6
pubmed: 27411749
Curr Neuropharmacol. 2009 Dec;7(4):331-6
pubmed: 20514212
Eur J Pain. 2008 Nov;12(8):1078-89
pubmed: 18367419
J Pain Res. 2017 Mar 03;10:515-525
pubmed: 28424559
Rheumatol Int. 2015 May;35(5):845-54
pubmed: 25903448
Compr Psychiatry. 2019 Apr;90:30-36
pubmed: 30684830
Arthritis Rheum. 2009 Jun 15;61(6):740-4
pubmed: 19479690
Psychogeriatrics. 2015 Jun;15(2):154-162
pubmed: 25516261
Mol Neurobiol. 2019 Feb;56(2):1137-1166
pubmed: 29876878
Brain Res Mol Brain Res. 1996 Mar;36(2):280-6
pubmed: 8965648
J Clin Psychol. 1987 Jul;43(4):402-9
pubmed: 3611374
J Psychosom Res. 1997 Mar;42(3):297-306
pubmed: 9130186
Neuropharmacology. 1998 Dec;37(12):1553-61
pubmed: 9886678
Daru. 2019 Jun;27(1):149-158
pubmed: 30877484
Neurosci Biobehav Rev. 2022 Apr;135:104558
pubmed: 35122780
Neuropsychology. 2015 Mar;29(2):173-82
pubmed: 25151113
Clin Rheumatol. 2013 Aug;32(8):1199-206
pubmed: 23604595
Neuropsychology. 2006 Sep;20(5):511-28
pubmed: 16938014
Adv Rheumatol. 2020 Jul 31;60(1):39
pubmed: 32736598
Arq Neuropsiquiatr. 2011 Dec;69(6):943-8
pubmed: 22297885
J Clin Med. 2021 Jul 21;10(15):
pubmed: 34361986
Front Hum Neurosci. 2016 Jun 27;10:308
pubmed: 27445748
J Gerontol A Biol Sci Med Sci. 2016 Mar;71(3):398-405
pubmed: 26433218
Hum Brain Mapp. 2016 Apr;37(4):1514-30
pubmed: 26821847
Neuron. 2007 Aug 2;55(3):377-91
pubmed: 17678852
Eur J Pain. 2012 Mar;16(3):421-9
pubmed: 22337559
PLoS One. 2018 Apr 25;13(4):e0196329
pubmed: 29694417
Assessment. 2001 Sep;8(3):323-38
pubmed: 11575625
Neuropsychology. 1997 Jan;11(1):138-46
pubmed: 9055277
Br J Pain. 2021 May;15(2):221-233
pubmed: 34055343
Neurology. 2008 Jul 15;71(3):217-21
pubmed: 18625968
Pain Med. 2000 Jun;1(2):156-72
pubmed: 15101904
Semin Arthritis Rheum. 2016 Dec;46(3):319-329
pubmed: 27916278
J Psychosom Res. 2011 Mar;70(3):294-301
pubmed: 21334501
Front Hum Neurosci. 2016 Jul 15;10:357
pubmed: 27471458
J Clin Rheumatol. 2004 Apr;10(2):53-8
pubmed: 17043464
J Psychiatr Res. 2005 Mar;39(2):207-14
pubmed: 15589570
Sci Transl Med. 2021 Nov 10;13(619):eabj7360
pubmed: 34757810
Neuropsychologia. 1974 Jul;12(3):323-30
pubmed: 4421777
Pain Med. 2020 Oct 1;21(10):2271-2279
pubmed: 32167540
J Affect Disord. 2008 Feb;106(1-2):1-27
pubmed: 17707915
J Pain Res. 2019 Jan 03;12:209-221
pubmed: 30655690
Psychosom Med. 2012 Oct;74(8):802-9
pubmed: 23006430
Front Psychol. 2021 May 21;12:673962
pubmed: 34093370
Pain. 2012 Jan;153(1):170-176
pubmed: 22119318
Front Psychol. 2018 Mar 22;9:377
pubmed: 29623059
Clin J Pain. 2016 Jun;32(6):541-54
pubmed: 26340657
J Pain Res. 2017 Sep 01;10:2109-2122
pubmed: 28979158